News

pharmaphorum22h
AZ, Daiichi get Datroway nod in lung cancer on second try
AZ and Daiichi Sankyo have claimed FDA approval for Datroway in lung cancer after switching indications for the TROP2-directed drug.
Targeted Oncology5h
Adjuvant Immunotherapy in High-Risk CSCC: Dr Koyfman’s KEYNOTE-630 Insights
Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical ...
Healio1h
FDA rejects Genentech’s glofitamab-gxbm for DLBCL, stymied by insufficient evidence
The FDA issued a complete response letter to Genentech indicating it cannot approve the company’s biologic license ...